Data as of Dec 09
| +0.53 / +1.05%|
The 17 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 54.00, with a high estimate of 60.00 and a low estimate of 29.00. The median estimate represents a +5.45% increase from the last price of 51.21.
The current consensus among 20 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since November, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.